Macedo, Diana2017-04-172017-06-302015-11http://hdl.handle.net/10362/20498Parkinson’s disease (PD) is the second most common neurodegenerative disease, and affects 1-2% of the population worldwide after the age of 65 years. Currently, there are only symptomatic treatment for PD and these do not mitigate the underlying causes of the disease.(...)engBiochemistryNeurosciencejournal article